臨床婦人科産科68巻6号

2014年06月発行

今月の臨床 性ホルモン製剤を使いこなす プロゲスチン製剤

1．種類と剤型

著者： 齊藤奈津穂¹ 山下能毅¹² 大道正英¹

所属機関： ¹大阪医科大学産婦人科 ²宮崎レディースクリニック

ページ範囲：P.538 - P.543

●新しいプロゲスチン製剤が開発され，製剤の種類，投与量，投与法などの選択の幅が増えている．

●静脈血栓塞栓症に対する影響を有することを念頭に使用しなければならない．

参考文献

1） Douketis JD, Ginsberg JS, Holbrook A, et al : A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. Arch Intern Med 157 : 522─530, 1997

2） Lidegaard Ø, Løkkegaard E, Jensen A, et al : Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 66 : 2257─2266, 2012

3） Oettel M, Carol W, Elger W, et al : “A 19-norprogestin without 17α-ethinyl group II : Dienogest from a pharmacodynamic point of view”. Drugs of Today 31 : 517─536, 1995

4） Schindler AE, Campagnoli C, Druckmann R, et al : Classification and pharmacology of progestins. Maturitas 61 : 171─180, 2008

5） Sasagawa S, Shimizu Y, Kami H, et al : Dienogest is selective progesterone receptor agonist in transactivation analaysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 73 : 222─231, 2008

6） Schindler AE, Campagnoli C, Druckmann R, et al : Progestins : present and future. J Steroid Biochem Molec Biol 59 : 357─363, 1996

7） Kuhl H : Pharmacology of progestins. Basic Aspects-Progesterone Derivatives. Menopause Review VI : 9─16, 2001

8） Rossouw JE, Anderson GL, Prentice RL, et al : Writing Group for the Women’s Health Initiative Investigators : Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288 : 321─333, 2002

9） Golbs S, Nikolov R, Zimmermann K : Pharmacology of Nortestosterone Derivatives. Menopause Review VI : 31─37, 2001

10） Harada T, Momoeda M, Terakawa N, et al : Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea : a placebo-controlled, double-blind, randomized trial. Fertil Steril 95 : 1928─1931, 2011

11） Harada T, Momoeda M, Taketani Y, et al : Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis : a placebo-controlled, double-blind, randomized trial. Fertil Steril 90 : 1583─1588, 2008

12） Rozenbaum H : Les Progestatifs ESKA, Paris, 2002

13） Strowitzki T, Marr J, Gerlinger C, et al : Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis : a 24-week, randomized, multicentre, open-label trial. Hum Reprod 25 : 633─641, 2010

14） McCormack PL : Dienogest : a review of its use in the treatment of endometriosis. Drugs 70 : 2073─2088, 2010

15） Mabrouk M, Solfrini S, Frascà C, et al : A new oral contraceptive regimen for endometriosis management : preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcg. Gynecol Endocrinol 28 : 451─454, 2012